MFG-IRAP gene therapy (University of Pittsburgh)

N/A

Report date: 2024/09/10 15:36:50

Base Information

Drug NameMFG-IRAP gene therapy (University of Pittsburgh)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A